Central Nervous System Agents in Medicinal Chemistry
Title: Editorial
Volume: 10 Issue: 1
Author(s): Maria L. Lopez-Rodriguez and Gregory S. Hamilton
Affiliation:
Export Options
About this article
Cite this article as:
Lopez-Rodriguez L. Maria and Hamilton S. Gregory, Editorial, Central Nervous System Agents in Medicinal Chemistry 2010; 10 (1) . https://dx.doi.org/10.2174/187152410790780163
DOI https://dx.doi.org/10.2174/187152410790780163 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
17
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
GABAergic Drugs for the Treatment of Migraine
CNS & Neurological Disorders - Drug Targets Modulatory Effects of Food Restriction on Brain and Behavioral Effects of Abused Drugs
Current Pharmaceutical Design Current and Future Therapeutic Strategies to Target Inflammation in Stroke
Current Drug Targets - Inflammation & Allergy Development of HuperTacrines as Non-Toxic, Cholinesterase Inhibitors for the Potential Treatment of Alzheimer’s Disease
Mini-Reviews in Medicinal Chemistry HDL Apolipoprotein-Related Peptides in the Treatment of Atherosclerosis and other Inflammatory Disorders
Current Pharmaceutical Design Editorial [Hot Topic: Depression (Part 2) (Guest Editors: Ronald S. Duman and John H. Kehne)]
CNS & Neurological Disorders - Drug Targets C5a, a Therapeutic Target in Sepsis
Recent Patents on Anti-Infective Drug Discovery Preface [Hot topic: Autoimmunity (Executive Editors: D. Stahl and W. Sibrowski)]
Current Pharmaceutical Design Ganoderma lucidum: A Potential for Biotechnological Production of Anti-Cancer and Immunomodulatory Drugs
Recent Patents on Anti-Cancer Drug Discovery Matter of Life and Death: the Pharmacological Approaches Targeting Apoptosis in Brain Diseases
Current Pharmaceutical Design A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Safety and Tolerability of Two Doses of Divalproex Sodium in Outpatients with Probable Alzheimers Disease
Current Alzheimer Research Mechanisms of Neuropathic Pain
Current Medicinal Chemistry - Central Nervous System Agents Impacts of Hyper-Homocysteinemia and White Matter Hyper-Intensity in Alzheimers Disease Patients with Normal Creatinine: An MRI-Based Study with Longitudinal Follow-up
Current Alzheimer Research In Silico Evaluation of Acetylation Mimics in the 27 Lysine Residues of Human Tau Protein
Current Alzheimer Research Comparative Corrosion Study of a New Type of “Ni-Free” Alloy for Decorative Applications
Recent Patents on Corrosion Science (Discontinued) New Insights on Dimethylaminoethanol (DMAE) Features as a Free Radical Scavenger
Drug Metabolism Letters Pharmacokinetics of CNT-based Drug Delivery Systems
Current Drug Metabolism Recent Developments in the Medicinal Chemistry of NK2 Receptor Antagonists
Current Topics in Medicinal Chemistry Editorial [Hot Topic: Multiple Sclerosis – From Bench to Bedside (Guest Editors: Sandra Amor and David Baker)]
CNS & Neurological Disorders - Drug Targets The Metaboloepigenetic Dimension of Cancer Stem Cells: Evaluating the Market Potential for New Metabostemness-Targeting Oncology Drugs
Current Pharmaceutical Design